歐盟掛保證 多國恢復打AZ疫苗

 Many European countries have suspended the use of AstraZeneca’s COVID-19 vaccine following reports of blood clots. However, Germany, France and several other EU countries on March 18th decided to continue using the AstraZeneca vaccine after the European Medicines Agency (EMA) shored up confidence in the shot.
 Following an investigation into 30 cases of unusual blood disorders, the EMA concluded that the vaccine’s benefits in protecting people from coronavirus outweighs the possible risks, though a link between blood clots and the shot could not be definitively ruled out.
 Germany resumed administering the AstraZeneca vaccine from March 19th. German Health Minister Jens Spahn said suspending the vaccine out of caution had been the right call. French Prime Minister Jean Castex received the shot himself on March 19th. It is up to individual EU states to decide whether and when to re-start vaccinations using the AstraZeneca vaccine.

 歐盟藥品管理局針對三十起罕見的血液失調病例進行調查後指出,雖然無法完全排除AZ疫苗與血栓之間的關聯性,但AZ 疫苗能安全有效的幫助民眾免於感染新冠肺炎,利多於弊。